How to measure congress success in pharma: from booth visitors to behavioural change

📊 Three levels of measurement: where are you?

Not all metrics are equal. The video introduces a clear way to think about the maturity of your congress measurement:

1. Level 1 — Activity measures 

   These are your raw numbers: how many people visited the booth, how many coffee cups were distributed. These are not worthless, but on their own they tell you very little. They only become useful when you put them in context.

2. Level 2 — Operational indicators 

   This is where measurement starts to become meaningful. A simple example: the number of booth visitors tells you something about booth attractiveness and visibility. The cost per booth visitor gives you a financial lens. The number of consents captured tells you about the quality of rep interactions.

3. Level 3 — Behavioural KPIs 

   This is the level that most organisations aspire to but few have reached. Here, you are no longer measuring what you did. You are measuring what changed. Did target HCPs increase their awareness of your brand? Did they move up the adoption ladder? Did any of this contribute to a change in clinical practice?

The honest message from the video: not every team will be at level three today. But understanding the difference between these levels is already a step forward.

 

🎯 The RACE model applied to congresses

One practical framework introduced in the video is the RACE model — originally from digital marketing, but very applicable to congress measurement:

• Reach: 

  How many of the right people did you get in front of? Not total attendees, not competitors, but your target HCPs specifically. If your product is not available in a given region, those visitors are not qualified leads, regardless of the volume.

• Act: 

  What actions were taken at the congress? Were badge scans captured? Were reps and MSLs actively collecting data? How many consents were obtained?

• Convert:

  Did interactions lead to something concrete? Medical information requests, MSL follow-up appointments, rep visit requests initiated during the event?

• Engage: 

  This can only be measured after the congress. How many follow-up visits were planned? How many consents were activated? How many re-contact meetings happened in the weeks that followed?

The value of this model is that it turns a congress from a standalone event into a journey that starts before the booth opens and continues long after the last session ends.
 

🏆 The "Olympic level": linking activity to impact

The most advanced measurement approach shown in the video connects every activity metric to a corresponding behavioural KPI.

For example:

• Booth visits and symposium attendance → percentage of target HCPs reached

• Time spent at the booth → brand awareness lift (measurable post-congress)

• Consent capture and follow-up meetings → movement along the adoption ladder

• All of the above, combined → contribution to change in clinical practice

This level of measurement requires investment: data infrastructure, alignment with your insights team. It is not simple to set up. But the logic behind it is straightforward, and even partial implementation moves you in the right direction.

 

✅ The key takeaway

The video ends with a clear principle that is worth keeping in mind every time you prepare a congress report:
We should not measure what we do. We should measure what it changes.

This means:

• Activities are your Reach

• Operational indicators are your Exposure

• KPIs are your Impact

If your congress reporting today is mostly activity measures, that is a starting point. The goal is to work progressively toward measurement that connects your investments to real outcomes for HCPs and for your business.